+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pravastatin"

From
Dyslipidemia Market Report 2025 - Product Thumbnail Image

Dyslipidemia Market Report 2025

  • Report
  • May 2025
  • 175 Pages
  • Global
From
Statins - Global Strategic Business Report - Product Thumbnail Image

Statins - Global Strategic Business Report

  • Report
  • July 2025
  • 192 Pages
  • Global
From
Statin Market 2025-2029 - Product Thumbnail Image

Statin Market 2025-2029

  • Report
  • March 2025
  • 210 Pages
  • Global
From
From
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Pravastatin is a cholesterol-lowering medication used to treat cardiovascular diseases. It belongs to a class of drugs known as statins, which work by blocking an enzyme in the liver that is responsible for producing cholesterol. Pravastatin is used to reduce the risk of heart attack, stroke, and other cardiovascular events in people with high cholesterol levels. It is also used to reduce the risk of developing heart disease in people with certain risk factors, such as diabetes, high blood pressure, or a family history of heart disease. Pravastatin is available in both generic and brand-name formulations. It is typically taken once daily, with or without food. Common side effects include headache, nausea, and muscle pain. The pravastatin market is highly competitive, with a number of companies offering generic and brand-name formulations. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and Mylan. Show Less Read more